S 640
116th Congress
Senate
Health
Health care costs and insurance
Health care quality
Health information and medical records
Inflation and prices
Medicare
Prescription drugs
Phair Pricing Act of 2019
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 4, 2019
Read twice and referred to the Committee on Finance.
Mar 4, 2019
Introduced in Senate
Plain-English summary
Phair Pricing Act of 2019
This bill requires that certain negotiated prices for covered drugs under the Medicare prescription drug benefit be disclosed at the point-of-sale.
Specifically, negotiated prices offered under a prescription drug plan (PDP) must be disclosed at the point-of-sale; the disclosed price must include specified adjustments, payments, and fees that are negotiated with the pharmacy (e.g., dispensing fees) by the PDP sponsor or pharmacy benefit manager.
Additionally, the Centers for Medicare & Medicaid Services must establish certain quality measures for PDP sponsors to use when determining incentive payments and adjustments (e.g., performance payments) to pharmacies.
What's happening now
Read twice and referred to the Committee on Finance.
Committees of jurisdiction
1